Loading chat...
MO SB1340
Bill
Status
1/7/2026
Primary Sponsor
Curtis Trent
Click for details
AI Summary
-
Health carriers and pharmacy benefits managers are prohibited from discriminating against 340B covered entities by reimbursing them less than similarly situated pharmacies for the same drugs
-
Prohibited discriminatory practices include imposing different fees, chargebacks, dispensing fees, network participation requirements, or audit requirements on 340B entities compared to non-340B pharmacies
-
Health carriers and PBMs cannot require covered entities to identify 340B drugs, refuse to cover 340B-purchased drugs, or require claim reversals/resubmissions solely due to 340B status
-
Violations subject to civil penalties of up to $5,000 per violation per day, enforced by the Director of the Department of Commerce and Insurance
-
Director must promulgate implementing rules; rulemaking authority expires August 28, 2026
Legislative Description
Modifies provisions relating to payments for prescription drugs, including 340B drugs
Last Action
Second Read and Referred S Families, Seniors and Health Committee
1/27/2026